MetaCap

Lexeo Therapeutics Statistics

NASDAQ: LXEOHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

2.96+0.01 (+0.34%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Lexeo Therapeutics by the numbers

Lexeo Therapeutics has a market capitalization of $245.1 million based on 82.79M shares outstanding. With trailing EPS of $-1.13, Lexeo Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 8.2% below its 50-day average and 39.3% below its 200-day average.

Average daily trading volume is 1.98M shares, or about $5.9 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

LXEO valuation vs. peer median

LXEO compared with the median of 8 peer companies
MetricLXEOPeer medianDifference
Market cap$245.05M$253.13M-3%
Avg. volume1.98M768.54K+157%

Peer median across 8 companies: PLX, AUTL, EDIT, SABS, EIKN, SCTX, OCGN, AGMB.

Valuation

Price and trading

Previous close
2.95
Open
2.93
Day range
2.89 – 3.25
52-week range
2.55 – 10.99
52-week change
-67.33%
Beta
—
Volume
1.80M

Dividends and events

Annual dividend
None
Next earnings date
Nov 16, 2026

Additional statistics

Market Cap
245.05M
Forward Pe
-2.00
Eps
-1.13
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
10.99
Week52 Low
2.55
Avg Volume
1.98M
Shares Outstanding
82.79M
Ma50
3.22
Ma200
4.88
Earnings Date
Nov 16, 2026
Pct From52w High
-73.07%
Pct From52w Low
16.08%

Related